Realising the potential of radioligand therapy: policy solutions for the barriers to implementation across Europe C. MerkelC. H. WhicherA. Chiti Editorial Open access 13 March 2020 Pages: 1335 - 1339
Editorial commentary to “18F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases” by Grkovski and colleagues Pierre LovinfosseSelma Ben MustaphaNadia Withofs Editorial 23 December 2019 Pages: 1340 - 1341
“Quid autem vides festucam in oculo fratris tui et trabem in oculo tuo non vide” on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake news Luca GiovanellaFrederik A. VerburgMarkus Luster Editorial 10 March 2020 Pages: 1342 - 1344
Brief progress report from the intersocietal working group on differentiated thyroid cancer Frederik A. VerburgSukhjeet AhujaDouglas Van Nostrand Editorial Open access 12 March 2020 Pages: 1345 - 1347
18F-FDG PET/CT and COVID-19 Beuy JoobViroj Wiwanitkit Letter to the Editor 12 March 2020 Pages: 1348 - 1348
Normalization by bone volume instead of body weight or lean body mass may be better for quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT Paulo Schiavom DuarteMarcelo Tatit Sapienza Letter to the Editor 10 January 2020 Pages: 1349 - 1350
Considerations on bone volume normalization in quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT Wouter van der BruggenLioe-Fee de Geus-OeiDennis Vriens Letter to the Editor 25 February 2020 Pages: 1351 - 1352
18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors Laure MichaudB. J. BeattieR. Blasberg Original Article Open access 15 August 2019 Pages: 1353 - 1367
TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study M. UnterrainerD. F. FleischmannN. L. Albert Original Article 05 September 2019 Pages: 1368 - 1380
Integration of dynamic parameters in the analysis of 18F-FDopa PET imaging improves the prediction of molecular features of gliomas Merwan GinetTimothée ZaragoriAntoine Verger Original Article 16 September 2019 Pages: 1381 - 1390
Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome Kerstin A. KesselWolfgang WeberStephanie E. Combs Original Article 22 November 2019 Pages: 1391 - 1399
Individualized discrimination of tumor recurrence from radiation necrosis in glioma patients using an integrated radiomics-based model Kai WangZhen QiaoLin Ai Original Article Open access 26 November 2019 Pages: 1400 - 1411
Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models Benjamin B. KastenKe JiangJason M. Warram Original Article 26 November 2019 Pages: 1412 - 1426
Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole (18F-FETNIM) PET/CT and overall survival in glioma patients Man HuYufang ZhuJinming Yu Original Article 28 November 2019 Pages: 1427 - 1434
Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric 18F-FET PET-MRI and MR Fingerprinting Johannes HauboldAydin DemirciogluLale Umutlu Original Article 06 December 2019 Pages: 1435 - 1445
18F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases Milan GrkovskiZachary A. KohutekKathryn Beal Original Article 21 December 2019 Pages: 1446 - 1457
Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study Shuangshuang SongYe ChengJie Lu Original Article Open access 09 January 2020 Pages: 1458 - 1467
Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas S. SchönJ. CabelloB. Wiestler Original Article Open access 17 January 2020 Pages: 1468 - 1475
Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapse Antoine LeimgruberKevin HicksonAndrew M Scott Original Article 05 February 2020 Pages: 1476 - 1485
Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET Elena K. BauerGabriele StoffelsNorbert Galldiks Original Article Open access 07 February 2020 Pages: 1486 - 1495
In vivo imaging of cell proliferation in meningioma using 3′-deoxy-3′-[18F]fluorothymidine PET/MRI Asma BashirTina BinderupIan Law Original Article 11 February 2020 Pages: 1496 - 1509
Succinate detection using in vivo 1H-MR spectroscopy identifies germline and somatic SDHx mutations in paragangliomas Charlotte Lussey-LepoutreAlexandre BellucciJudith Favier Original Article 13 December 2019 Pages: 1510 - 1517
Prevalence of hyperfunctioning thyroid nodules among those in need of fine needle aspiration cytology according to ATA 2015, EU-TIRADS, and ACR-TIRADS Benjamin NotoMaria EveslagePeter Kies Original Article Open access 09 March 2020 Pages: 1518 - 1526
Quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT Wouter van der BruggenMarlous Hagelstein-RotmanDennis Vriens Original Article 24 December 2019 Pages: 1527 - 1537
Atherosclerosis imaging with 18F-sodium fluoride PET: state-of-the-art review Poul F. Høilund-CarlsenMichael SturekOke Gerke Review Article Open access 27 November 2019 Pages: 1538 - 1551
Paediatric nuclear medicine practice: an international survey by the IAEA G. L. PoliL. TorresF. Fahey Original Article Open access 08 December 2019 Pages: 1552 - 1563
Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA Christian SchmidkonzManuela KrumbholzMarkus Metzler Original Article 18 December 2019 Pages: 1564 - 1575
FDG-PET assessment and metabolic patterns in Lafora disease Lorenzo MuccioliAndrea FarolfiFrancesca Bisulli Original Article 19 December 2019 Pages: 1576 - 1584
Etiologic classification of infantile spasms using positron emission/magnetic resonance imaging and the efficacy of adrenocorticotropic hormone therapy Haodan DangLiping ZouBaixuan Xu Original Article 03 January 2020 Pages: 1585 - 1595
Role of FDG-PET/CT in children with fever of unknown origin Jordy P. PijlThomas C. KweeAndor W.J.M. Glaudemans Original Article Open access 07 February 2020 Pages: 1596 - 1604
Tumor uptake in glioblastoma multiforme after IV injection of [177Lu]Lu-PSMA-617 Jolanta KunikowskaIngeborga CharzyńskaLeszek Królicki Image of the Month Open access 10 February 2020 Pages: 1605 - 1606
FDG-PET/CT in the detection of pituitary stalk ACTH-secreting adenoma Ziren KongYu WangXin Cheng Image of the Month 18 December 2019 Pages: 1607 - 1608
Correction to: Superior performance of 18F-fluorocholine digital PET/CT in the detection of parathyroid adenomas Diego Alfonso López-MoraMarina SizovaIgnasi Carrió Correction 16 March 2020 Pages: 1609 - 1609
Correction to: A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB Soo Hyun ChoYeong Sim ChoeSang Won Seo Correction 13 February 2020 Pages: 1610 - 1610
Correction to: Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes Jun Pyo KimJeonghun KimJoon-Kyung Seong Correction 10 February 2020 Pages: 1611 - 1612
Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA Christian SchmidkonzManuela KrumbholzMarkus Metzler Correction 13 February 2020 Pages: 1613 - 1613